- Reaction score
- 12
http://replicel.com/20170314-2/
-(That is the data for you to look at)
I am aware that the results/aim of the study was to measure safety, and it's great that RCH-01 appears safe... However, the actual hair regrowth in subjects seems very dispersed and lacklustre. They stress that going forward with repeat injections and improved administration, efficacy and overall regrowth will be better, but how much better when responsiveness on average appears quite poor?
Previous companies have investigated DP cell cultivation/injections and they have discarded this. Shiseido and Replicel are using the same technique but with DSC's. I know they stress multiple injection sessions will yield improved results, but it's still a little disconcerting that a similar concept has been tried and disregarded.
Could someone interpret the results, and tell me if I am just being a massive idiot, or whether the likelihood of this being an effective treatment is bleak? Thanks
-(That is the data for you to look at)
I am aware that the results/aim of the study was to measure safety, and it's great that RCH-01 appears safe... However, the actual hair regrowth in subjects seems very dispersed and lacklustre. They stress that going forward with repeat injections and improved administration, efficacy and overall regrowth will be better, but how much better when responsiveness on average appears quite poor?
Previous companies have investigated DP cell cultivation/injections and they have discarded this. Shiseido and Replicel are using the same technique but with DSC's. I know they stress multiple injection sessions will yield improved results, but it's still a little disconcerting that a similar concept has been tried and disregarded.
Could someone interpret the results, and tell me if I am just being a massive idiot, or whether the likelihood of this being an effective treatment is bleak? Thanks